These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 16311896)

  • 21. Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders.
    Leijala J; Kampman O; Suvisaari J; Eskelinen S
    BMC Psychiatry; 2021 Jan; 21(1):37. PubMed ID: 33441112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors.
    Klingberg S; Schneider S; Wittorf A; Buchkremer G; Wiedemann G
    Psychiatry Res; 2008 Nov; 161(2):225-34. PubMed ID: 18922582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.
    San L; Ciudad A; Alvarez E; Bobes J; Gilaberte I
    Eur Psychiatry; 2007 Nov; 22(8):490-8. PubMed ID: 17904337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient outcomes in schizophrenia II: the impact of cognition.
    Hofer A; Baumgartner S; Bodner T; Edlinger M; Hummer M; Kemmler G; Rettenbacher MA; Fleischhacker WW
    Eur Psychiatry; 2005 Aug; 20(5-6):395-402. PubMed ID: 16171654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients.
    Ritsner M; Modai I; Endicott J; Rivkin O; Nechamkin Y; Barak P; Goldin V; Ponizovsky A
    J Clin Psychiatry; 2000 Nov; 61(11):880-9; quiz 890. PubMed ID: 11105747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.
    Mohamed S; Rosenheck R; McEvoy J; Swartz M; Stroup S; Lieberman JA
    Schizophr Bull; 2009 Mar; 35(2):336-46. PubMed ID: 18586692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia.
    Granholm E; McQuaid JR; McClure FS; Auslander LA; Perivoliotis D; Pedrelli P; Patterson T; Jeste DV
    Am J Psychiatry; 2005 Mar; 162(3):520-9. PubMed ID: 15741469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
    Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
    Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Subjective quality of life of schizophrenic patients. Effect of treatment setting, psychopathology and extrapyramidal motor drug effects].
    Kemmler G; Meise U; Tasser A; Liensberger D; Schifferle I; Braitenberg M; Schwitzer J; Hinterhuber H
    Psychiatr Prax; 1999 Jan; 26(1):9-15. PubMed ID: 10087570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of quality of life among people diagnosed with schizophrenia at outpatient clinics.
    Hasan AA; Tumah H
    Perspect Psychiatr Care; 2019 Jan; 55(1):30-39. PubMed ID: 29645261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathways to functional outcomes in schizophrenia: the role of premorbid functioning, negative symptoms and intelligence.
    Brill N; Levine SZ; Reichenberg A; Lubin G; Weiser M; Rabinowitz J
    Schizophr Res; 2009 May; 110(1-3):40-6. PubMed ID: 19297133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia.
    Adelufosi AO; Ogunwale A; Abayomi O; Mosanya JT
    Psychiatry Res; 2013 Oct; 209(3):320-5. PubMed ID: 23452754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attitudes toward menstruation in females with schizophrenia or schizoaffective disorders in Taiwan.
    Liang HY; Lee LW; Kelsen BA; Hsu SC; Liu CY; Chen CY
    Climacteric; 2013 Dec; 16(6):682-8. PubMed ID: 23205628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative contributions of psychotic symptoms and insight to quality of life in stable schizophrenia.
    Rocca P; Castagna F; Mongini T; Montemagni C; Bogetto F
    Psychiatry Res; 2010 May; 177(1-2):71-6. PubMed ID: 20381879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study.
    Mortimer AM; Al-Agib AO
    Int J Soc Psychiatry; 2007 Mar; 53(2):99-107. PubMed ID: 17472084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in schizophrenia outpatients treated with amisulpride or olanzapine.
    Hofer A; Rettenbacher MA; Edlinger M; Huber R; Bodner T; Kemmler G; Sachs G; Fleischhacker WW
    Pharmacopsychiatry; 2007 Jan; 40(1):1-8. PubMed ID: 17327953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-Year Quality-of-Life Outcomes of Patients with Schizophrenia and Schizoaffective Disorders: The Relationship with Unmet Needs for Care.
    Ritsner MS; Grinshpoon A
    Clin Schizophr Relat Psychoses; 2015; 9(3):125-34A. PubMed ID: 23491971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.